Seroprevalence of Toxoplasma gondii, varicella zoster virus and human parvovirus B19 among women in the Biała Podlaska District of Eastern Poland

• Autorzy: Tokarska-Rodak M. , Paszkiewicz J. , Laskowski K. , Plewik D. , Chwedczuk M.
• Języki publikacji: EN

Abstrakty

EN

Background: Infections in pregnant women or women planning pregnancy caused by the protozoan Toxoplasma gondii and the viruses varicella zoster virus (VZV) and human parvovirus B19 can be a danger to the fetus. Aim of the study: The aim of the study was to determine the serological status of women of childbearing age in relation to T. gondii, VZV and human parvovirus B19 in a region of Eastern Poland (Biała Podlaska District). Material and methods: The study group consisted of 174 women aged 19 to 35 (average 23, SD 3.68) from the Biała Podlaska District. Anti-T. gondii IgM/IgG antibodies, anti-VZV IgG and anti-human parvovirus B19 IgG were detected by ELISA. Results: Serological screening revealed that the most common antibodies were anti-VZV and anti-parvovirus B19 (in 96% and 60.9% of women, respectively). Anti-T. gondii antibodies were found in 28.6%. No correlation was found between the presence of anti-T. gondii, human parvovirus B19, and VZV antibodies and the age of the examined women, their place of residence, and their education. Conclusions: About 4%, 39% and 71.2% of women participating in this study were still susceptible to infection with VZV, human parvovirus B19, and T. gondii, respectively. It is therefore important to address health education primarily in women of childbearing age in order to help them undertake relevant measures for prevention of T. gondii, human parvovirus B19 and VZV infection.

• Wydawca: -
• Czasopismo: Medical Science Pulse
• Rocznik: 2019
• Tom: 13
• Numer: 4
• Opis fizyczny: p.17-22,ref.

Twórcy

autor

Tokarska-Rodak M.

• Faculty of Health and Social Sciences, Pope John Paul II State School of Higher Education, Biała Podlaska, Poland

autor

Paszkiewicz J.

• Faculty of Health and Social Sciences, Pope John Paul II State School of Higher Education, Biała Podlaska, Poland

autor

Laskowski K.

• Faculty of Health and Social Sciences, Pope John Paul II State School of Higher Education, Biała Podlaska, Poland

autor

Plewik D.

• Faculty of Health and Social Sciences, Pope John Paul II State School of Higher Education, Biała Podlaska, Poland

autor

Chwedczuk M.

• Innovation Research Centre, Pope John Paul II State School of Higher Education, Biała Podlaska, Poland

Bibliografia

• 1. Kapka L, Perżyło K, Cyranka M, Skrzypczak M, Wdowiak L. Toksoplazmoza wrodzona jako aktualny problem zdrowotny. Zdr Publ 2010; 120(1): 80–86. (In Polish).
• 2. Milewska-Bobula B, Lipka B, Gołąb E, Dębski R, Marczyńska M, Paul M, et al. Recommended management of Toxoplasma gondii infection in pregnant women and their children. Przegl Epidemiol 2015; 69: 291–298.
• 3. Sullivan WJ Jr, Jeffers V. Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol Rev 2012; 36(3): 717–733.
• 4. Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, Hall AJ. Seroprevalence of cytomegalovirus, Epstein Barr virus and Varicella zoster virus among pregnant women in Bradford: a cohort study. 2013; PLoS ONE 8(11): e81881 [online] [cit. 20.02.2019] Available from URL: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081881.
• 5. Lamont RF, Sobel DJ, Carrington D, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, et al. Varicella zoster virus (chickenpox) infection in pregnancy. BJOG 2011; 118(10): 1155–1162.
• 6. Majidy P, Khodabandehloo M, Azadi NA. Seroprevalence of Varicella zoster virus antibody among young women before marriage in Sanandaj, Iran. IJM 2016; 8(2): 147–152.
• 7. Zajkowska A, Garkowski A, Czupryna P, Moniuszko A, Król ME, Szamatowicz J, et al. Seroprevalence of parvovirus B19 antibodies among young pregnant women or planning pregnancy, tested for toxoplasmosis. Przegl Epidemiol 2015; 69: 479–482.
• 8. Habibzadeh S, Doghaheh HP, Shahi JM, Mobini E, Sshahbazzadegan S. The prevalence of parvovirus B19 infection among pregnant women of Ardabil in 2013. IJM 2016; 8(3): 214–218.
• 9. Mossong J, Hens N, Friederichs V, Davidkin I, Broman M, Litwinska B, et al. Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect 2008; 136: 1059–1068.
• 10. Abiodun I, Opaleye O, Ojurongbe O, Fagbami A. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria. J Infect Dev Ctries 2013; 7(12): 946–950.
• 11. EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control). The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2015. EFSA Journal 2016; 14(12): 4634.
• 12. Czarkowski MP, Cielebąk E, Staszewska-Jakubik E, Kondej B. Choroby zakaźne i zatrucia w Polsce w 2016 roku [online] 2017 [cit. 9.08.2019]. Available from URL: http://wwwold.pzh.gov.pl/oldpage/epimeld/2016/Ch_2016.pdf. (In Polish).
• 13. Czarkowski MP, Kondej B, Staszewska-Jakubik E, Cielebąk E. Szczepienia ochronne w Polsce w 2016 roku [online] 2017 [cit. 9.08.2019]. Available from URL: http://wwwold.pzh.gov.pl/oldpage/epimeld/2016/Sz_2016.pdf. (In Polish).
• 14. Czarkowski MP, Cielebąk E, Kondej B, Staszewska E. Choroby zakaźne i zatrucia w Polsce w 2008 roku [online] 2009 [cit. 9.08.2019]. Available from URL: http://wwwold.pzh.gov.pl/oldpage/epimeld/2008/Ch_2008.pdf. (In Polish).
• 15. Gangneux FR, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012; 25(2): 264–296.
• 16. Sroka J, Wójcik-Fatla A, Szymańska J, Dutkiewicz J, Zając V, Zwoliński J. The occurrence of Toxoplasma gondii infection in people and animals from rural environment of Lublin region – estimate of potential role of water as a source of infection. Ann Agric Environ Med 2010; 17: 111–118.
• 17. Drapała D, Holec-Gąsior L. Diagnostyka toksoplazmozy u kobiety ciężarnej, płodu i noworodka – stan obecny i nowe możliwości. Forum Medycyny Rodzinnej 2013; 7(4): 176–184. (In Polish).
• 18. Myjak P, Głowniak C, Gołąb E, Jaborowska-Jarmoluk M, KosikBogacka D, Matowicka-Karna J, et al. Standardy w zakresie laboratoryjnych czynności w parazytologii medycznej, oceny ich jakości i wartości diagnostycznej oraz laboratoryjnej interpretacji i autoryzacji wyników badań (propozycje). Diagnostyka Laboratoryjna 2011; 47(3): 341–351. (In Polish).
• 19. Sroka J, Szymańska J. Analysis of prevalence of Toxoplasma gondii infection in selected rural households in the Lublin region. Bull Vet Inst Pulawy 2012; 56: 529–534.
• 20. Lewicka M, Dziedziczak-Buczyńska M, Mawlichanów K, Buczyński A. Ocena występowania toksoplazmozy u kobiet ciężarnych w środowisku miejsko-wiejskim powiatu giżyckiego w odniesieniu do populacji ogólnokrajowej. Hygeia Public Heath 2013; 48(3): 320–326. (In Polish).
• 21. Eliášová A, Tokarska-Rodak M, Laskowski K, Pawłowicz E, Fiedoruk M, Magurová D, et al. Knowledge of nursing students about the transmission and prevention of infections caused by Toxoplasma gondii, Rubella virus, Cytomegalovirus in women during pregnancy. Health Problems of Civilization 2017; 11(1): 40–44.
• 22. Grabarczyk P, Kalińska A, Litwińska B, Celewicz Z, Dębska M, Nowakowska D, et al. Diagnostyka laboratoryjna zakażenia parvowirusem B19 u kobiet w ciąży. Rekomendacje polskiej grupy ekspertów [online] 2014 [cit. 9.08.2019]. Available from URL: https://kidl.org.pl/file/file/get?id=157_06ciaza-z-okladka.pdf. (In Polish).
• 23. Gerson AA. Zakażenia wirusem ospy wietrznej-półpaśca. Pediatr Dypl 2009; 13(4): 54–59. (In Polish).
• 24. Cieślik-Tarkota R, Lorenc Z, Albertyńska M, Rozwadowska B, Jasik KP, Mendera-Bożek U. The epidemiological situation of chickenpox in silesian voivodeship in the years 2011–2015 in view of data of the situation in Poland. Przegl Epidemiol 2016; 70(4): 555–562.
• 25. Korczyńska MR, Rogalska J. Chickenpox in Poland in 2014. Przegl Epidemiol 2016; 70(2): 189–193.
• 26. Jurkowska U, Majewska A, Dmoch-Gajzlerska E, Młynarczyk G. Zakażenie alfaherpeswirusami u kobiet w ciąży i ryzyko okołoporodowego zakażenia płodu i noworodka. Nowa Pediatria 2011; 3: 66–71. (In Polish).
• 27. Talukder YS, Kafatos G, Pinot de Moira A, Aquilina J, Parker SP, Crowcroft NS, et al. The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK. Epidemiol Infect 2007; 135: 1344–1353.
• 28. van Rijckevorsel GGC, Damen M, Sonder GJ, van der Loeff MFS, van den Hoek A. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population. BMC Infectious Diseases 2012; 12: 140.
• 29. Siennicka J, Stefanoff P, Trzcińska A, Rosiñska M, Litwińska B. Przegląd serologiczny w kierunku zakażenia parwowirusem B19 w Polsce. Przegl Epidemiol 2006; 60(3): 571–580. (In Polish).

Identyfikatory

DOI

10.5604/01.3001.0013.7160